Astrana Health (NASDAQ:ASTH) Reaches New 1-Year Low - Here's Why

Key Points

• Astrana Health shares hit a new 52-week low, trading as low as $22.45 before closing at $22.50, representing a significant drop from its previous closing price of $23.44.
• Analysts have a consensus rating of "Moderate Buy" for Astrana Health, with Barclays setting a target price of $36.00, despite the company missing earnings expectations with $0.14 EPS compared to a consensus of $0.23.
• Recent trading activity shows that institutional investors are increasing their positions in Astrana Health, with 52.77% of the stock now owned by hedge funds and institutional investors.

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) shares reached a new 52-week low during trading on Friday . The stock traded as low as $22.45 and last traded at $22.50, with a volume of 326375 shares trading hands. The stock had previously closed at $23.44.

Analyst Upgrades and Downgrades

Separately, Barclays began coverage on Astrana Health in a report on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 target price for the company. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, Astrana Health currently has a consensus rating of "Moderate Buy" and an average price target of $53.29.

Astrana Health Trading Down 4.0%

The business has a fifty day moving average of $24.90 and a 200-day moving average of $29.91. The stock has a market capitalization of $1.26 billion, a price-to-earnings ratio of 31.25, a price-to-earnings-growth ratio of 0.86 and a beta of 0.84. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.70 and a quick ratio of 1.70.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). Astrana Health had a return on equity of 4.90% and a net margin of 1.56%. The firm had revenue of $620.39 million for the quarter, compared to analyst estimates of $628.11 million. During the same period in the previous year, the firm earned $0.31 earnings per share. Astrana Health's revenue was up 53.4% on a year-over-year basis. On average, equities analysts anticipate that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Astrana Health

A number of hedge funds and other institutional investors have recently made changes to their positions in ASTH. Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of Astrana Health during the 4th quarter worth approximately $40,000. Quarry LP increased its position in shares of Astrana Health by 35.5% during the fourth quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after purchasing an additional 471 shares during the period. Covestor Ltd increased its position in shares of Astrana Health by 777.6% during the first quarter. Covestor Ltd now owns 2,001 shares of the company's stock valued at $62,000 after purchasing an additional 1,773 shares during the period. AlphaQuest LLC increased its position in shares of Astrana Health by 144.2% during the first quarter. AlphaQuest LLC now owns 4,883 shares of the company's stock valued at $151,000 after purchasing an additional 2,883 shares during the period. Finally, US Bancorp DE increased its position in shares of Astrana Health by 21.3% during the first quarter. US Bancorp DE now owns 5,791 shares of the company's stock valued at $180,000 after purchasing an additional 1,015 shares during the period. 52.77% of the stock is owned by hedge funds and other institutional investors.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.